UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 375

Sortiert nach

Psychometric properties of the Japanese version of the EQ-5D-Y by self-report and proxy-report: reliability and construct validity

Quality of life research, 2019-11, Vol.28 (11), p.3093-3105

2019

Volltextzugriff (PDF)

Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial

British journal of cancer, 2011-10, Vol.105 (9), p.1273-1278

2011

Volltextzugriff (PDF)

Japanese value set for the EORTC QLU-C10D: A multi-attribute utility instrument based on the EORTC QLQ-C30 cancer-specific quality-of-life questionnaire

Quality of life research, 2024-07, Vol.33 (7), p.1865-1879

2024

Volltextzugriff (PDF)

Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial

Quality of life research, 2017-02, Vol.26 (2), p.445-453

2017

Volltextzugriff (PDF)

Basic Attitude Of Japanese Physicians Towards Healthcare Resource Allocation In A Setting Of Budget Constraints

Value in health, 2015-11, Vol.18 (7), p.A532-A532

2015

Volltextzugriff (PDF)

HTA42 Vignette-Based Estimation of Utilities in Patients with Metastatic Breast Cancer in Japan

Value in health, 2024-06, Vol.27 (6), p.S252-S252

2024

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Treatment in Japan

Value in health, 2013-11, Vol.16 (7), p.A415-A416

2013

Volltextzugriff (PDF)

A Comparison of Value for Health States Worse Than Dead Between Japan and Uk

Value in health, 2014-11, Vol.17 (7), p.A514-A514

2014

Volltextzugriff (PDF)

EE158 Economic Evaluation of Duvelisib Versus Ofatumumab in Relapsed/Refractory CLL/SLL in Japan

Value in health, 2024-06, Vol.27 (6), p.S86-S87

2024

Volltextzugriff (PDF)

PHP10 The Margin Between Acquisition Costs and Reimbursement Prices of Generic Drugs (yakkasa) in Japan: Current Status and Determinants

Value in health, 2012-11, Vol.15 (7), p.A611-A611

2012

Volltextzugriff (PDF)

PRM4 QALY and Productivity Loss: Empirical Evidence for “Double Counting”

Value in health, 2012-11, Vol.15 (7), p.A645-A646

2012

Volltextzugriff (PDF)

EE508 Cost-Effectiveness Analysis of Pembrolizumab for Advanced Colorectal Cancer with MSI-High or dMMR in Japan

Value in health, 2024-06, Vol.27 (6), p.S150-S151

2024

Volltextzugriff (PDF)

EE504 Cost-Effectiveness Analysis of Tremelimumab As First-Line Therapy for Metastatic Non-Small Cell Lung Cancer in Japan

Value in health, 2024-06, Vol.27 (6), p.S150-S150

2024

Volltextzugriff (PDF)

EE66 Cost-Effectiveness Analysis of Pembrolizumab + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer in Japan

Value in health, 2024-06, Vol.27 (6), p.S69-S69

2024

Volltextzugriff (PDF)

EE289 Cost-Effectiveness Analysis of Blinatumomab for Advanced Acute Lymphoblastic Leukemia in Japan

Value in health, 2024-06, Vol.27 (6), p.S111-S111

2024

Volltextzugriff (PDF)

Assessment of Response Shift and True Change Using Structural Equation Modeling for Health–Related Quality-of-Life Scores in Patients with Breast Cancer After Surgery

Value in health, 2014-05, Vol.17 (3), p.A94-A94

2014

Volltextzugriff (PDF)

Reanalysis of Cost-Effectiveness of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer in Japan Using a Japanese Claim Data Set

Value in health, 2014-05, Vol.17 (3), p.A85-A86

2014

Volltextzugriff (PDF)

Using Structural Equation Modeling to Detect Response Shift and True Change in Health-Related Quality-Of-Life Scores of Breast Cancer Patients After Surgery

Value in health, 2013-11, Vol.16 (7), p.A602-A602

2013

Volltextzugriff (PDF)

Basic Attitude Towards Health Care Resource Allocation Decision Making in Japanese People -Utilitarianism or Egalitarianism?

Value in health, 2013-11, Vol.16 (7), p.A469-A469

2013

Volltextzugriff (PDF)

Measurement of Societal Medical Care Preferences with the Same Cost Per Qaly: A Discrete Choice Study

Value in health, 2013-11, Vol.16 (7), p.A336-A337

2013

Volltextzugriff (PDF)

Prospective Validation of Patient Neurotoxicity Questionnaire (PNQ) for Assessment of Oxaliplatin Neurotoxicty: CSP-HOR 16

Annals of oncology, 2012-09, Vol.23, p.ix512-ix513

2012

Volltextzugriff (PDF)

HTA7 Cost-Effectiveness Analysis of Nivolumab Plus Chemotherapy Vs Chemotherapy in Patients with Advanced Gastric Cancer in Japan

Value in health, 2022-07, Vol.25 (7), p.S505

2022

Volltextzugriff (PDF)

PCN132 A Development of Quality Indicators for Evaluating Home Palliative Care and Their Relation with Bereaved Family Satisfaction

Value in health, 2011, Vol.14 (7), p.A458-A458

2011

Volltextzugriff (PDF)

Comparing the Performance of the EQ-5D-5L with the EQ-5D-3L in Stroke Patients in Japan

Value in health, 2013-11, Vol.16 (7), p.A534-A534

2013

Volltextzugriff (PDF)

POSC280 Economic Evaluation of Nivolumab Plus Ipilimumab in Advanced Renal-Cell Carcinoma in Japan

Value in health, 2022-01, Vol.25 (1), p.S188-S189

2022

Volltextzugriff (PDF)

1 – 25 von 375

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(335)
Mit Volltextzugriff
(332)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(178)
Physics
(106)
Physical Sciences
(101)
Technology
(65)
Physics, Fluids & Plasmas
(59)
Humans
(55)
Female
(46)
Nuclear Science & Technology
(39)
Exact Sciences And Technology
(34)
Life Sciences & Biomedicine
(32)
Middle Aged
(31)
Physics, Applied
(30)
Plasma
(30)
70 Plasma Physics And Fusion Technology
(29)
Internal Medicine
(28)
Condensed Matter Physics
(27)
Adult
(26)
Nuclear Energy And Engineering
(26)
Lhd Device
(25)
Male
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Psychometric properties of the Japanese version of the EQ-5D-Y by self-report and proxy-report: reliability and construct validity

Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial

Japanese value set for the EORTC QLU-C10D: A multi-attribute utility instrument based on the EORTC QLQ-C30 cancer-specific quality-of-life questionnaire

Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial

Basic Attitude Of Japanese Physicians Towards Healthcare Resource Allocation In A Setting Of Budget Constraints

HTA42 Vignette-Based Estimation of Utilities in Patients with Metastatic Breast Cancer in Japan

Cost-Effectiveness Analysis of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Treatment in Japan

A Comparison of Value for Health States Worse Than Dead Between Japan and Uk

EE158 Economic Evaluation of Duvelisib Versus Ofatumumab in Relapsed/Refractory CLL/SLL in Japan

PHP10 The Margin Between Acquisition Costs and Reimbursement Prices of Generic Drugs (yakkasa) in Japan: Current Status and Determinants

PRM4 QALY and Productivity Loss: Empirical Evidence for “Double Counting”

EE508 Cost-Effectiveness Analysis of Pembrolizumab for Advanced Colorectal Cancer with MSI-High or dMMR in Japan

EE504 Cost-Effectiveness Analysis of Tremelimumab As First-Line Therapy for Metastatic Non-Small Cell Lung Cancer in Japan

EE66 Cost-Effectiveness Analysis of Pembrolizumab + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer in Japan

EE289 Cost-Effectiveness Analysis of Blinatumomab for Advanced Acute Lymphoblastic Leukemia in Japan

Assessment of Response Shift and True Change Using Structural Equation Modeling for Health–Related Quality-of-Life Scores in Patients with Breast Cancer After Surgery

Reanalysis of Cost-Effectiveness of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer in Japan Using a Japanese Claim Data Set

Using Structural Equation Modeling to Detect Response Shift and True Change in Health-Related Quality-Of-Life Scores of Breast Cancer Patients After Surgery

Basic Attitude Towards Health Care Resource Allocation Decision Making in Japanese People -Utilitarianism or Egalitarianism?

Measurement of Societal Medical Care Preferences with the Same Cost Per Qaly: A Discrete Choice Study

Prospective Validation of Patient Neurotoxicity Questionnaire (PNQ) for Assessment of Oxaliplatin Neurotoxicty: CSP-HOR 16

HTA7 Cost-Effectiveness Analysis of Nivolumab Plus Chemotherapy Vs Chemotherapy in Patients with Advanced Gastric Cancer in Japan

PCN132 A Development of Quality Indicators for Evaluating Home Palliative Care and Their Relation with Bereaved Family Satisfaction

Comparing the Performance of the EQ-5D-5L with the EQ-5D-3L in Stroke Patients in Japan

POSC280 Economic Evaluation of Nivolumab Plus Ipilimumab in Advanced Renal-Cell Carcinoma in Japan

Suchergebnisse filtern